Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors

QR Code

Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors

Background Targeting epidermal growth factor receptor (EGFR) has become a strategic approach in cancer therapy, using various modalities including chimeric antigen receptor (CAR)-αβT cell therapies. Despite significant advancements in autologous CAR-αβT cell therapies in B-cell lymphoma, current cel...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi-Chiu Kuo, Hao-Kang Li, Tai-Sheng Wu, Ying Ru, Chia-Yun Lee, Pei-Ju Leng, Yi-Chun Hsieh, Yun-Jung Chiang, Zih-Fei Cheng, Yan-Liang Lin, Shih-Chia Hsiao, Sai-Wen Tang
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-07-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/7/e010500.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeted siRNA Delivery Using Cetuximab‐Conjugated Starch for Epidermal Growth Factor Receptor‐Driven Head and Neck Squamous Cell Carcinoma
by: Chen Benafsha, et al.
Published: (2025-07-01)

Successful Treatment of Osimertinib Resistance in an EGFR‐Mutant Lung Cancer Patient With a Rare STRN3‐ALK Fusion Using Brigatinib and Osimertinib
by: Chia‐Yu Kuo, et al.
Published: (2025-07-01)

Regulatory T-cells and allogeneic hematopoietic stem cell transplantation
by: O. S. Karavaeva, et al.
Published: (2022-12-01)

ADI-270: an armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignancies
by: Jie Zhang, et al.
Published: (2025-07-01)

EGFR gene copy number as a prognostic marker in colorectal cancer patients treated with cetuximab or panitumumab: a systematic review and meta analysis.
by: Zheng Jiang, et al.
Published: (2013-01-01)

The role of cetuximab in the treatment of patients with squamous cell carcinoma of the head and neck: resolution of the Expert Council
Published: (2019-01-01)

Single‐cell sequencing analysis reveals cetuximab resistance mechanism and salvage strategy in colorectal cancer
by: Shiyun Chen, et al.
Published: (2025-01-01)

Critical Review: Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer
by: Anita Ramesh
Published: (2025-07-01)

Combination of concurrent targeted and immune-therapy with nivolumab and cetuximab: new perspectives for squamous cell carcinoma treatment
by: A. M. Mudunov, et al.
Published: (2020-11-01)

Reply to: Critical Review: Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer
by: Kumar Prabhash, et al.
Published: (2025-07-01)

Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR‐mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis
by: Shang‐Gin Wu, et al.
Published: (2025-01-01)

Allogeneic Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria
by: Miroslaw, Markiewicz, et al.
Published: (2012)

Chemotherapy with cetuximab in head and neck squamous cell carcinoma: immunological aspects and markers of treatment effectiveness in clinical practice
by: A. I. Stukan, et al.
Published: (2024-06-01)

Conjugated Polymers for Organic Solar Cells
by: Ye, Qun, et al.
Published: (2011)

Anti-monocyte globulin in allogeneic transplantation of hematopoietic stem cells
by: Yu. R. Zalyalov, et al.
Published: (2022-11-01)

Requirements for diploid allogenic cell lines used for regenerative medicine
by: O. I. Konyushko, et al.
Published: (2018-08-01)

Monitoring of chimerism after allogeneic hematopoietic stem cell transplantation
by: D. S. Dubnyak, et al.
Published: (2022-12-01)

Current Status and Future Prospects of Treatment for EGFR-Positive Non-Small Cell Lung Cancer After Resistance to EGFR-TKI
by: Yiming ZENG, et al.
Published: (2025-06-01)

Imbalanced NK cell subpopulations and TIGIT expression limit cetuximab efficacy in colorectal cancer: A promising target for treatment enhancement
by: Carmen Navarrete‐Sirvent, et al.
Published: (2025-06-01)

Systematic Review and Meta-Analysis on Incidence of Altered Sensation of Mandibular Implant Surgery.
by: Chia-Shu Lin, et al.
Published: (2016-01-01)

Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma
by: Chenglin Zhang, et al.
Published: (2025-06-01)

Development of iPSC-derived T cells targeting EGFR neoantigens in non-small cell lung cancer
by: Kouta Niizuma, et al.
Published: (2025-09-01)

GAMMA DELTA (γδ) T CELLS: ORIGIN, PHENOTYPE, FUNCTIONS
by: Dmitry Sokolov
Published: (2019-08-01)

Graft failure in allogeneic hematopoietic stem cell recipients: diagnosis and treatment
by: U. V. Maslikova, et al.
Published: (2023-03-01)

Clinical impact of first-line therapeutic strategies in BRAF V600E-mutant metastatic colorectal cancer: real-world evidence and prognostic insight
by: Chia-Chang Yeh, et al.
Published: (2025-07-01)

eIg-based bispecific T-cell engagers targeting EGFR: Format matters
by: Lennart Kühl, et al.
Published: (2023-12-01)

Influence of allogeneic mesenchymal stem cells on leukemic cells <i>in vitro</i> sensitivity to antileukemic drugs
by: O. S. Tatarinova, et al.
Published: (2022-11-01)

Elucidating the Role of FASN in Lung Cancer Stem Cells in Sensitive and Resistant EGFR-Mutated Non-Small Cell Lung Cancer Cells
by: Polonio-Alcalá E, et al.
Published: (2025-05-01)

Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation
by: A. S. Frolova, et al.
Published: (2022-11-01)

Autoimmune neutropenia: a rare complication of allogeneic hematopoietic stem cell transplantation?
by: María Isabel Benítez Carabante, et al.
Published: (2025-07-01)

Revolutionizing Allogeneic Graft Tolerance Through Chimeric Antigen Receptor-T Regulatory Cells
by: Alvin Man Lung Chan, et al.
Published: (2025-07-01)

STUDY OF VEGF-A AND TGF-Β LEVELS IN BIOPTATES OF SQUAMOUS CELL CARCINOMA OF THE TONGUE AND MOUTH FLOOR MUCOSA IN POLYCHEMOTHERAPY WITH MONOCLONAL ANTIBODIES – CETUXIMAB
by: O. I. Kit, et al.
Published: (2019-09-01)

Highly Diverse Efficacy of Salvage Treatment Regimens for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review.
by: Ya-Ting Yang, et al.
Published: (2016-01-01)

Curing Monitoring of Composite Material Using Embedded Fiber Bragg Grating Sensors
by: Chiang, Chia-Chin
Published: (2011)

Proteomic Study of Esophageal Squamous Cell Carcinoma
by: Qi, Yi-Jun, et al.
Published: (2012)

Spontaneous Spinal Epidural Hematoma – A Case Report and Literature Review
by: Hsieh-Liang Shih, et al.
Published: (2025-07-01)

Coastal Morphological Modeling
by: Chiang, Yun-Chih, et al.
Published: (2011)

Dynamics of changes in expression of VEGF neoangiogenic factor in tumor tissue bioptates in patients with squamous cell carcinoma of oral mucosa receiving cetuximab treatment and chemotherapy
by: A. A. Lyanova, et al.
Published: (2022-12-01)

Safety and Feasibility of Blockade of NK Group-2 Member-A Receptor in Natural Killer Cells Combined with Cetuximab Antibody in Patients with Advanced Gastric Adenocarcinoma
by: Maryam Samareh-Salavatipour, et al.
Published: (2025-04-01)

Measuring cell for microwave properties studying of delta-doped diamond samples
by: V. V. Vitko, et al.
Published: (2015-06-01)